MedTrace Logo

Dry vs Wet Misoprostol for Cervical Dilation in First Trimester Abortion

NCT02522078 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2016-03-25

No results posted yet for this study

Summary

This study aims to verify whether the moisture of 400 µg of misoprostol pre uterine evacuation increases the dilatation of uterine cervix compared to dry misoprostol

Conditions

  • Abortion Early

Interventions

DRUG

dry misoprostol

400 µg of dry misoprostol will be introduced into the vaginal fornices 3 or more hours before uterine evacuation

DRUG

wet misoprostol

400 µg of wet misoprostol will be introduced into the vaginal fornices 3 or more hours before uterine evacuation

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Ricardo F Savaris, MD, PhD · Hospital de Clínicas de Porto Alegre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02522078 on ClinicalTrials.gov